Canadian pork producer calls for transparency in GM pork labeling

Canadian organic pork producer duBreton is pushing for mandatory labeling of genetically modified pork across North America, regardless of its origin.

The request comes after the U.S. Food and Drug Administration (FDA) recently approved the import of PRRS-resistant pigs into the United States starting in 2026. The agency approved the commercial distribution of pigs that can be modified using clustered regularly interspaced short palindromic repeats (CRISPR) technology.

Proponents of the technology claim it will reduce animal suffering and limit the use of antibiotics , but DuBreton says these claims are misleading and without basis.

“We have been achieving the same results for decades without genetic modification,” said Vincent Breton, president of duBreton. “Through natural breeding, selective breeding and strict biosecurity protocols, duBreton produces healthy pigs without antibiotics, while maintaining the principles of organic farming.”

An organic pork company has cited ethical and long-term concerns for its opposition to gene editing in livestock production.

The company also noted that the practice does not meet the standards of the Global Animal Partnership (GAP), Certified Humane Raised & Handled, and USDA Organic. The company argues that the FDA's actions leave unanswered questions about animal welfare and consumer safety.

DuBreton's proposal, filed this week, calls on the FDA, USDA, CFIA and HEALTH CANADA to mandate labeling of both domestic and imported genetically modified pork products. The company also seeks specific regulations that would distinguish genetically modified pork from conventional and organic MEAT products.

“The lack of labeling of genetically modified pork is a direct threat to consumer trust and the viability of ethical and sustainable agriculture,” added Breton. “Transparent labeling is essential for consumer choice. Without it, responsible producers are at a disadvantage when they refuse to compromise their values.”

duBreton operates four organic pork processing plants, one of which is located in the United States.  

Genus developed PRRS-resistant pigs and received approval in April. At the time, the company emphasized the importance of getting approval to sell the pigs in key U.S. EXPORT markets such as Mexico, Canada and Japan .

“The FDA approval is an exceptional achievement for Genus PIC and an important step towards commercialization in the U.S.,” said Jorgen Kocke, CEO of Genus. “We will continue to pursue regulatory approvals in other international jurisdictions, with a particular focus on key U.S. export markets.”